PUMA BIOTECHNOLOGY INC shareholders Q1 2023

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 79 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

PUMA BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,537,6321.98%
Eversept Partners, LP 1,938,088$5,988,6920.42%
Camber Capital Management LP 4,235,000$13,0860.40%
Hillsdale Investment Management Inc. 834,103$2,577,3780.22%
GLOBEFLEX CAPITAL L P 561,530$1,735,1280.21%
Kynam Capital Management, LP 473,070$1,461,7860.19%
Affinity Asset Advisors, LLC 177,349$548,0080.18%
CORNERCAP INVESTMENT COUNSEL INC 124,919$386,0000.07%
RICE HALL JAMES & ASSOCIATES, LLC 367,497$1,135,5660.06%
XTX Topco Ltd 81,619$252,2030.05%
ACADIAN ASSET MANAGEMENT LLC 1,874,859$5,7920.02%
Patriot Financial Group Insurance Agency, LLC 36,000$111,2400.02%
Prospera Financial Services Inc 100,072$309,2040.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,400$458,5560.01%
Crestline Management, LP 31,884$98,5220.01%
CAXTON ASSOCIATES LP 24,610$76,0450.01%
PDT Partners, LLC 21,946$67,8130.01%
683 Capital Management, LLC 36,500$112,7850.01%
Renaissance Technologies 1,834,913$5,6700.01%
MILLENNIUM MANAGEMENT LLC 2,985,835$9,2260.01%
External links

This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q1 2023. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.